Skip to main content
. 2026 May 20;48(1):2671466. doi: 10.1080/0886022X.2026.2671466

Table 1.

Context-dependent mechanisms of the lactate-lactylation axis in kidney disease.

Disease model Implicated cell type/compartment Lactate axis component & target site Major phenotype Evidence type References
Sepsis (CLP) HK-2 Lactylation machinery: Fis1 K20 Mitochondrial dysfunction (Injury) Perturbation (in vivo/in vitro) [67]
Sepsis (CLP) HK-2 Lactylation machinery: H3K18 and Ezrin K263 Inflammation/apoptosis Perturbation (in vivo/in vitro) [65]
Sepsis (CLP) Macrophages Lactylation machinery: HMGB1 NET formation Perturbation (in vivo/in vitro) [69]
I/R-AKI HK-2 Lactylation machinery: H3K18 Enhanced glycolysis Perturbation (in vivo/in vitro) [70]
I/R-AKI TEC Lactylation machinery: c-Myc TEC proliferation Perturbation (in vivo/in vitro) [64]
CDDP/MA-AKI HK-2 Lactylation machinery: ALDH2 K52 Mitochondrial dysfunction (Injury) Perturbation (in vivo/in vitro) [71]
Lactate-AKI HK-2 Lactylation machinery: HMGB1 NET formation Perturbation (in vivo/in vitro) [72]
DN (db/db) HK-2/mTEC Lactylation machinery: H3K14 EMT Perturbation (in vivo/in vitro) [73]
DN (STZ) MPC Lactylation machinery: Histones EMT of podocytes Perturbation (in vivo/in vitro) [74]
DN (db/db) HK-2 Lactylation machinery: ACSF2 K182 Mitochondrial dysfunction Associative (in vivo/in vitro) [75]
DN (STZ) mRTEC Lactylation machinery: H3 Fibrosis Perturbation (in vivo/in vitro) [76]
DN (STZ) GEnCs Lactylation machinery: H3K18 Endomt/Fibrosis Perturbation (in vivo/in vitro) [77]
DN (STZ) HK-2 Lactylation machinery: TRIM65 K206 Enhanced glycolysis Perturbation (in vivo/in vitro) [78]
DN (STZ) HPCs Lactylation machinery: LARS1 K970 Inhibition of podocyte autophagy Perturbation (in vivo/in vitro) [79]
LN (PBMC immune reconstruction) MC/HEK293 Lactylation machinery: PBX1 K40 Proliferation of MC Perturbation (in vivo/in vitro) [80]
UUO-CKD HK-2 Lactylation machinery: H4K12 M2 polarization Perturbation (in vivo/in vitro) [66]
CDDP-CKD BUMPT Lactylation machinery: H3K18 Fibrosis Perturbation (in vivo/in vitro) [81]

CLP: Cecal Ligation and Puncture; HK-2: Human Kidney-2 cells; Fis1: Mitochondrial fission 1 protein; H3K18: Histone H3 lysine 18; Ezrin: Ezrin protein; HMGB1: High Mobility Group Box 1; NET: Neutrophil Extracellular Trap; I/R-AKI: Ischemia/Reperfusion-Induced Acute Kidney Injury; TEC: Tubular Epithelial Cells; c-Myc: Cellular Myelocytomatosis oncogene; CDDP/MA-AKI: Cisplatin/Mannitol-Induced Acute Kidney Injury; ALDH2: Aldehyde Dehydrogenase 2; Lactate-AKI: Lactate-Induced Acute Kidney Injury; DN: Diabetic Nephropathy; db/db: Diabetic (db/db) mouse model; mTEC: Mouse Tubular Epithelial Cells; H3K14: Histone H3 lysine 14; STZ: Streptozotocin; MPC: Mouse Podocyte Cells; ACSF2: Acyl-CoA Synthetase Family Member 2; mRTEC: Mouse Renal Tubular Epithelial Cells; H3: Histone H3; GEnCs: Glomerular Endothelial Cells; TRIM65: Tripartite Motif Containing 65; HPCs: Human Podocyte Cells; LARS1: Leucyl-tRNA Synthetase 1; LN: Lupus Nephritis; PBMC: Peripheral Blood Mononuclear Cells; MC: Mesangial Cells; HEK293: Human Embryonic Kidney 293 cells; PBX1: Pre-B-Cell Leukemia Homeobox 1; UUO-CKD: Unilateral Ureteral Obstruction-Induced Chronic Kidney Disease; M2: M2 macrophage phenotype; H4K12: Histone H4 lysine 12; CDDP-CKD: Cisplatin-Induced Chronic Kidney Disease; BUMPT: Boston University Mouse Proximal Tubule cell line.